Mounjaro News

Mounjaro is an FDA-approved medication by Eli Lilly that reduces cardiovascular risk in type 2 diabetes patients.

Share

Mounjaro Approved to Reduce Heart Event Risk in Type 2 Diabetes Patients

Mounjaro approved to cut heart risks in type 2 diabetes

Novo Nordisk Sues Eli Lilly Over Alleged Misleading Advertising for Obesity Drugs

Novo Nordisk sues Eli Lilly over obesity drug ads

Mounjaro is an FDA-approved medication by Eli Lilly that reduces cardiovascular risk in type 2 diabetes patients.